Disposition and functions of clarithromycin in human THP-1 monocytes during stimulated and unstimulated conditions

T J Ives1, U E Schwab, E S Ward

  • 1Division of Pharmacotherapy, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Research Communications in Molecular Pathology and Pharmacology
|May 23, 2003
PubMed

Insights

Clarithromycin uptake by monocytes is pH-dependent and affects inflammatory mediator release. Later treatment may block infection spread by modulating inflammation and enhancing bacterial killing.

Area of Science:

  • Immunology
  • Pharmacology
  • Microbiology

Background:

  • Macrolide antibiotics are bacteriostatic, inhibiting protein synthesis.
  • Phagocytic cells like monocytes internalize pathogens.
  • Macrolides may impede infection spread via inflammation modulation.

Purpose of the Study:

  • Investigate clarithromycin uptake and effects in human THP-1 monocytes.
  • Determine clarithromycin's impact on inflammatory mediator release and monocyte function.
  • Assess clarithromycin's role in controlling infection and inflammation.

Main Methods:

  • Monocyte cell culture (THP-1).
  • Clarithromycin uptake and efflux assays at varying pH.
  • Measurement of inflammatory mediators (NO, H2O2, IL-1, TNFalpha).
  • Assay of hydrolytic enzymes (NAG, cathepsin D) and enzyme activities (PKC, SOD).

Main Results:

  • Clarithromycin uptake by monocytes is pH-dependent, utilizing carrier and passive processes.
  • Initial clarithromycin exposure triggers inflammatory mediator release and enzyme activity.
  • Prolonged exposure (2-4 hr) reduces mediator release and enzyme activity, potentially blocking inflammation spread.
  • Bacteriostatic effects observed at 24 hr, but not 2 hr, for both extracellular and phagocytosed bacteria.

Conclusions:

  • Clarithromycin exhibits complex interactions with monocytes, influencing inflammatory responses.
  • The antibiotic's ability to modulate inflammation suggests a role in limiting infection dissemination.
  • Further research is warranted to explore clarithromycin's therapeutic potential in inflammatory conditions and infections.